Aarvik Therapeutics
Hayward, California, United States · Biotechnology, Healthcare, Health Care
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Hayward, California, United States
- Employees
- 10
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- aarviktx.com
- Company page
Recent activity at Aarvik Therapeutics
- : Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India.
- : Aarvik Therapeutics has secured a successful Series Seed 2 financing round. This funding will help advance the company's proprietary MUTTA™ platform and reach targeted research milestones.
- : Aarvik Therapeutics
Employee benefit plans
Aarvik Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Aarvik Therapeutics: questions and answers
What does Aarvik Therapeutics do?
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
Where is Aarvik Therapeutics headquartered?
Aarvik Therapeutics is headquartered in Hayward, California, United States.
How many employees does Aarvik Therapeutics have?
Aarvik Therapeutics has about 10 employees.
What is the latest news on Aarvik Therapeutics?
On Nov 03, 2026, Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy